OPKO Health, Inc. Temporary Equity, Carrying Amount (Deprecated 2012-01-31)
OPKO Health, Inc. (OPK) had Temporary Equity, Carrying Amount (Deprecated 2012-01-31) of $24.39 million as of 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Notes
us-gaap:TemporaryEquityCarryingAmount · last filed 2012-05-10
- 2012-03-31: Temporary Equity, Carrying Amount (Deprecated 2012-01-31) $24.39M.
- 2011-12-31: Temporary Equity, Carrying Amount (Deprecated 2012-01-31) $24.39M.
- 2011-09-30: Temporary Equity, Carrying Amount (Deprecated 2012-01-31) $26.13M.
- 2011-06-30: Temporary Equity, Carrying Amount (Deprecated 2012-01-31) $26.13M.
| Period end | Temporary Equity, Carrying Amount (Deprecated 2012-01-31) |
|---|---|
| 2012-03-31 | $24.39M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $24.39M 10-Q · filed 2012-05-10 |
| 2011-09-30 | $26.13M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $26.13M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $26.13M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |